|

ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy

RECRUITINGSponsored by Stiftung Swiss Tumor Institute
Actively Recruiting
SponsorStiftung Swiss Tumor Institute
Started2022-03-21
Est. completion2025-04-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05354973

Summary

This study is designed as a feasibility study implementing electronic Patient Reported Outcomes (ePRO) in CAR T treatment for hematological malignancies, in order to describe AE reporting. ePRO assessments will be explored for their feasibility to engage in monitoring and management of CAR T-related toxicities as well as using these digital ePRO tools may improve both, its safety and accessibility.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Signed ICF
2. Patients \> 18 years
3. Patients receiving CAR T cell treatment
4. Personal smartphone with iOS or Android system. The operating system must be updated to one of the two newest main versions.

Exclusion Criteria:

1. Patients, whose compliance to the studies' protocol, e.g. due to mental health problems, physical problems, or the private life situation, can be justifiably doubted.
2. Patients with insufficient knowledge about the use of a smartphone.

Conditions3

CAR T Cell TherapyCancerPatient Reported Outcome Measures

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.